Chickenpox in adults - Clinical management

Journal of Infection

Volumn 57, Issue 2, 2008, Pages 95-102

  Tunbridge, A J ^a   Breuer, J ^b   Jeffery, K J M ^c   on behalf of the British Infection Society, ^d  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d NONE

Author keywords

Aciclovir; Adult; Chickenpox; Pregnancy; Severe infection; Varicella

Indexed keywords

ACICLOVIR; ANTIPRURITIC AGENT; ANTIVIRUS AGENT; CHICKENPOX VACCINE; FAMCICLOVIR; PENCICLOVIR; PLACEBO; VALACICLOVIR; VARICELLA ZOSTER VACCINE;

BACTERIAL INFECTION; BLEEDING; CHICKENPOX; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTACT DERMATITIS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ERUPTION; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; EMERGENCY CARE; ERYTHEMA MULTIFORME; GRAFT VERSUS HOST REACTION; HEALTH PROGRAM; HERPES ZOSTER; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOPATHOGENESIS; IMPETIGO; INFECTION PREVENTION; INFECTION RISK; MEDICAL DECISION MAKING; MOUTHWASH; PITYRIASIS ROSEA; PNEUMONIA; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREGNANCY; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SCABIES; STEVENS JOHNSON SYNDROME; TREATMENT DURATION; UNITED KINGDOM; VARICELLA ZOSTER VIRUS; VESICULAR RASH; VIRUS ISOLATION; VIRUS REACTIVATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ADOLESCENT; ADULT; CHICKENPOX; CHICKENPOX VACCINE; HERPESVIRUS 3, HUMAN; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC;

EID: 48349147410     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2008.03.004     Document Type: Review

References (51)

1. Vyse A.J., Gay N.J., Hesketh L.M., Morgan-Capner P., and Miller E. Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol Infect 132 (2004) 1129-1134
2. Lee B.W. Review of varicella zoster seroepidemiology in India and Southeast Asia. Trop Med Int Health 3 11 (1998 Nov) 886-890
3. Lolekha S., Tanthiphabha W., Sornchai P., Kosuwan P., Sutra S., Warachit B., et al. Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. Am J Trop Med Hyg 64 3-4 (2001 Mar-Apr) 131-136
4. Fairley C.K., and Miller E. Varicella-zoster virus epidemiology-a changing scene?. J Infect Dis 174 Suppl. 3 (1996) S314-S319
5. Miller E., Marshall R., and Vurdien J. Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol 4 (1993) 222-230
6. Rawson H., Crampin A., and Noah N. Deaths from chickenpox in England and Wales 1995-1997: analysis of routine mortality data. BMJ 323 7321 (2001 Nov 10) 1091-1093
7. Brisson M., and Edmunds W.J. Epidemiology of varicella-zoster virus in England and Wales. J Med Virol 70 Suppl. 1 (2003) S9-S14
8. Department of Health. Varicella. Available from: (2004). gov.uk/assetRoot/04/07/31/40/04073140.pdf
9. Health Protection Agency. General information - chickenpox (Varicella). Available from:. hpa.org.uk/infections/topics_az/chickenpox/gen_info.htm
10. Watson B., Civen R., Reynolds M., Heath K., Perella D., Carbajal T., et al. Validity of self-reported varicella disease history in pregnant women attending prenatal clinics. Public Health Rep 122 4 (2007 July-Aug) 499-506
11. Thomas S.L., Wheeler J.G., and Hall A.J. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 360 9334 (2002 Aug 31) 678-682
12. Balfour Jr. H.H. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment. Scand J Infect Dis Suppl 80 (1991) 69-74
13. David D.S., Tegtmeier B.R., O'Donnell M.R., Paz I.B., and McCarty T.M. Visceral varicella-zoster after bone marrow transplantation: report of a case series and review of the literature. Am J Gastroenterol 93 5 (1998 May) 810-813
14. Bovill B., and Bannister B. Review of 26 years' hospital admissions for chickenpox in North London. J Infect 36 Suppl. 1 (1998 Jan) 17-23
15. Nathwani D., Maclean A., Conway S., and Carrington D. Varicella infections in pregnancy and the newborn. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect 36 Suppl. 1 (1998 Jan) 59-71
16. Jones A.M., Thomas N., and Wilkins E.G. Outcome of varicella pneumonitis in immunocompetent adults requiring treatment in a high dependency unit. J Infect 43 2 (2001 Aug) 135-139
17. Tarlow M.J., and Walters S. Chickenpox in childhood. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect 36 Suppl. 1 (1998 Jan) 39-47
18. Wallace M.R., Bowler W.A., Murray N.B., Brodine S.K., and Oldfield III E.C. Treatment of adult varicella with oral acyclovir. A randomized, placebo-controlled trial. Ann Intern Med 117 5 (1992 Sep 1) 358-363
19. Balfour Jr. H.H., Edelman C.K., Anderson R.S., Reed N.V., Slivken R.M., Marmor L.H., et al. Controlled trial of acyclovir for chickenpox evaluating time of initiation and duration of therapy and viral resistance. Pediatr Infect Dis J 20 10 (2001 Oct) 919-926
20. Balfour H.H., Rotbart H.A., Feldman S., Dunkle L.M., Feder Jr. H.M., Prober C.G., et al. Aciclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Aciclovir Varicella Study Group. J Pediatr 120 4 Pt 1 (1992) 627-633
21. Klassen T.P., Belseck E.M., Wiebe N., and Hartling L. Acyclovir for treating varicella in otherwise healthy children and adolescents: a systematic review of randomised controlled trials. BMC Pediatr 2 (2002 Sep 30) 9
22. Wilkins E.G., Leen C.L., McKendrick M.W., and Carrington D. Management of chickenpox in the adult. A review prepared for the UK Advisory Group on chickenpox on behalf of the British Society for the Study of Infection. J Infect 36 Suppl. 1 (1998 Jan) 49-58
23. Jacobson M.A. Valaciclovir (BW256U87): the L-valyl ester of acyclovir. J Med Virol Suppl. 1 (1993) 150-153
24. Beutner K.R., Friedman D.J., Forszpaniak C., Andersen P.L., and Wood M.J. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 39 7 (1995 Jul) 1546-1553
25. Grant D.M., Mauskopf J.A., Bell L., and Austin R. Comparison of valaciclovir and acyclovir for the treatment of herpes zoster in immunocompetent patients over 50 years of age: a cost-consequence model. Pharmacotherapy 17 2 (1997 Mar-Apr) 333-341
26. Tyring S.K., Beutner K.R., Tucker B.A., Anderson W.C., and Crooks R.J. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 9 9 (2000 Sep-Oct) 863-869
27. Breuer J., and Whitley R. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster. Herpes 14 Suppl. 2 (2007 Sep) 25-29
28. Mohsen A.H., and McKendrick M. Varicella pneumonia in adults. Eur Respir J 21 5 (2003 May) 886-891
29. Whitley R.J. Therapeutic approaches to varicella-zoster virus infections. J Infect Dis 166 Suppl. 1 (1992 Aug) S51-S57
30. Smith K.J., and Roberts M.S. Cost effectiveness of early treatment with oral aciclovir in adult chickenpox. Pharmacoeconomics 13 5 Pt 2 (1998 May) 645-651
31. Joint Formulary Committee. British national formulary. 54th ed. (Sept 2007), British Medical Association and Royal Pharmaceutical Society of Great Britain, London
32. Ogilvie M.M. Antiviral prophylaxis and treatment in chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect 36 Suppl. 1 (1998 Jan) 31-38
33. Mer M., and Richards G.A. Corticosteroids in life-threatening varicella pneumonia. Chest 114 2 (1998 Aug) 426-431
34. Harger J.H., Ernest J.M., Thurnau G.R., Moawad A., Momirova V., Landon M.B., et al. Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis 185 4 (2002 Feb 15) 422-427
35. Royal College of Obstetricians and Gynaecologists. Green top Guidelines no 13. Chickenpox in Pregnancy. Available from: (reviewed Sept 2007). http://www.rcog.org.uk/resources/Public/pdf/greentop13_chickenpox0907.pdf
36. Birthistle K., and Carrington D. Fetal varicella syndrome - a reappraisal of the literature. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect 36 Suppl. 1 (1998 Jan) 25-29
37. Harger J.H., Ernest J.M., Thurnau G.R., Moawad A., Thom E., Landon M.B., et al. Frequency of congenital varicella syndrome in a prospective cohort of 347 pregnant women. Obstet Gynecol 100 2 (2002 Aug) 260-265
38. Tan M.P., and Koren G. Chickenpox in pregnancy: revisited. Reprod Toxicol 21 4 (2006 May) 410-420 [Epub 2005 June 23]
39. Enders G., Miller E., Cradock-Watson J., Bolley I., and Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 343 8912 (1994 Jun 18) 1548-1551
40. Meyers J.D. Congenital varicella in term infants: risk reconsidered. J Infect Dis 129 2 (1974 Feb) 215-217
41. Kimberlin D.F., Weller S., Whitley R.J., Andrews W.W., Hauth J.C., Lakeman F., et al. Pharmacokinetics of oral valaciclovir and acyclovir in late pregnancy. Am J Obstet Gynecol 179 4 (1998 Oct) 846-851
42. Jacquemard F., Yamamoto M., Costa J.M., Romand S., Jaqz-Aigrain E., Dejean A., et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 114 9 (2007 Sep) 1113-1121
43. Varicella. Chapter 34. Immunisation against infectious disease, "The Green Book" (2006), Department of Health, London. http://www.dh.gov.uk/en/Policyandguidance/Healthandsocialcaretopics/Greenbook/DH_4097254 Available from:
44. Balfour Jr. H.H., McMonigal K.A., and Bean B. Acyclovir therapy of varicella-zoster virus infections in immunocompromised patients. J Antimicrob Chemother 12 Suppl. B (1983 Sep) 169-179
45. Davis M.M. Successes and remaining challenges after 10 years of varicella vaccination in the USA. Expert Rev Vaccines 5 2 (2006 Apr) 295-302
46. Sengupta N., Booy R., Schmitt H.J., Peltola H., Van-Damme P., Schumacher R.F., et al. Varicella vaccination in Europe: are we ready for a universal childhood programme. Eur J Pediatr 167 1 (2008 Jan) 47-55
47. Marin M., Guris D., Chaves S.S., Schmid S., and Seward J.F. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56 RR-4 (2007 Jun 22) 1-40. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm Available from:
48. MacMahon E., Brown L.J., Bexley S., Snashall D.C., and Patel D. Identification of potential candidates for varicella vaccination by history: questionnaire and seroprevalence study. BMJ 329 7465 (2004 Sep 4) 551-552
49. Evans E.B., Pollock T.M., Cradock-Watson J.E., and Ridehalgh M.K. Human anti-chickenpox immunoglobulin in the prevention of chickenpox. Lancet 1 (1980) 354-356
50. Chickenpox. Chapter 7. Immunoglobulin handbook (2007), Centre for InfectionsHealth Protection Agency, Colindale. http://www.hpa.org.uk/infections/topics_az/immunoglobulin/pdfs/chickenpox.pdf Handbook available from:
51. The British HIV Association Immunisation Guidelines for HIV-infected adults. 1st ed. (April 2006). http://www.bhiva.org/files/file1001634.pdf Available from: